MOLECULAR PATHOLOGY PROCEDURE, LEVEL 4 (EG, ANALYSIS OF SINGLE EXON BY DNA SEQUENCE ANALYSIS, ANALYSIS OF >10 AMPLICONS USING MULTIPLEX PCR IN 2 OR MORE INDEPENDENT REACTIONS, MUTATION SCANNING OR DUPLICATION/DELETION VARIANTS OF 2-5 EXONS) ANG (ANGIOGENIN, RIBONUCLEASE, RNASE A FAMILY, 5) (EG, AMYOTROPHIC LATERAL SCLEROSIS), FULL GENE SEQUENCE ARX (ARISTALESS RELATED HOMEOBOX) (EG, X-LINKED LISSENCEPHALY WITH AMBIGUOUS GENITALIA, X-LINKED INTELLECTUAL DISABILITY), DUPLICATION/DELETION ANALYSIS CEL (CARBOXYL ESTER LIPASE [BILE SALT-STIMULATED LIPASE]) (EG, MATURITY-ONSET DIABETES OF THE YOUNG [MODY]), TARGETED SEQUENCE ANALYSIS OF EXON 11 (EG, C.1785DELC, C.1686DELT) CTNNB1 (CATENIN [CADHERIN-ASSOCIATED PROTEIN], BETA 1, 88KDA) (EG, DESMOID TUMORS), TARGETED SEQUENCE ANALYSIS (EG, EXON 3) DAZ/SRY (DELETED IN AZOOSPERMIA AND SEX DETERMINING REGION Y) (EG, MALE INFERTILITY), COMMON DELETIONS (EG, AZFA, AZFB, AZFC, AZFD) DNMT3A (DNA [CYTOSINE-5-]-METHYLTRANSFERASE 3 ALPHA) (EG, ACUTE MYELOID LEUKEMIA), TARGETED SEQUENCE ANALYSIS (EG, EXON 23) EPCAM (EPITHELIAL CELL ADHESION MOLECULE) (EG, LYNCH SYNDROME), DUPLICATION/DELETION ANALYSIS F8 (COAGULATION FACTOR VIII) (EG, HEMOPHILIA A), INVERSION ANALYSIS, INTRON 1 AND INTRON 22A F12 (COAGULATION FACTOR XII [HAGEMAN FACTOR]) (EG, ANGIOEDEMA, HEREDITARY, TYPE III; FACTOR XII DEFICIENCY), TARGETED SEQUENCE ANALYSIS OF EXON 9 FGFR3 (FIBROBLAST GROWTH FACTOR RECEPTOR 3) (EG, ISOLATED CRANIOSYNOSTOSIS), TARGETED SEQUENCE ANALYSIS (EG, EXON 7) (FOR TARGETED SEQUENCE ANALYSIS OF MULTIPLE FGFR3 EXONS, USE 81404) GJB1 (GAP JUNCTION PROTEIN, BETA 1) (EG, CHARCOT-MARIE-TOOTH X-LINKED), FULL GENE SEQUENCE GNAQ (GUANINE NUCLEOTIDE-BINDING PROTEIN G[Q] SUBUNIT ALPHA) (EG, UVEAL MELANOMA), COMMON VARIANTS (EG, R183, Q209) HUMAN ERYTHROCYTE ANTIGEN GENE ANALYSES (EG, SLC14A1 [KIDD BLOOD GROUP], BCAM [LUTHERAN BLOOD GROUP], ICAM4 [LANDSTEINER-WIENER BLOOD GROUP], SLC4A1 [DIEGO BLOOD GROUP], AQP1 [COLTON BLOOD GROUP], ERMAP [SCIANNA BLOOD GROUP], RHCE [RH BLOOD GROUP, CCEE ANTIGENS], KEL [KELL BLOOD GROUP], DARC [DUFFY BLOOD GROUP], GYPA, GYPB, GYPE [MNS BLOOD GROUP], ART4 [DOMBROCK BLOOD GROUP]) (EG, SICKLE-CELL DISEASE, THALASSEMIA, HEMOLYTIC TRANSFUSION REACTIONS, HEMOLYTIC DISEASE OF THE FETUS OR NEWBORN), COMMON VARIANTS HRAS (V-HA-RAS HARVEY RAT SARCOMA VIRAL ONCOGENE HOMOLOG) (EG, COSTELLO SYNDROME), EXON 2 SEQUENCE KCNC3 (POTASSIUM VOLTAGE-GATED CHANNEL, SHAW-RELATED SUBFAMILY, MEMBER 3) (EG, SPINOCEREBELLAR ATAXIA), TARGE